Opioid-modulating Peptides: Mechanisms of Action

Author(s): Catherine Mollereau, Michel Roumy, Jean-Marie Zajac

Journal Name: Current Topics in Medicinal Chemistry

Volume 5 , Issue 3 , 2005

Become EABM
Become Reviewer


Opioids are involved in the physiological control of numerous functions of the central nervous system, particularly nociception. It appears that some endogenous neuropeptides, called “anti-opioids“, participate in an homeostatic system tending to reduce the effects of opioids. Neuropeptide FF (NPFF) and cholecystokinin (CCK) possess these properties and, paradoxically, the opioid peptides nociceptin and dynorphin display some anti-opioid activity. All these peptides exhibit complex properties as they are able to both counteract and potentiate opioid activity, acting rather as modulators of opioid functions. The purpose of this review is to highlight that two different mechanisms are clearly involved in the control of opioid functions by opioid-modulating peptides: a “circuitry-induced” mechanism for nociceptin and dynorphin, and a “cellular anti-opioid” mechanism for NPFF and CCK. The knowledge of these mechanisms has potential therapeutic interest in the control of opioid functions, notably for alleviating pain and/or for the treatment of opioid abuse.

Keywords: opioids, neuropeptide ff, nociceptin/orphanin fq, cholecystokinin, morphine, pain, analgesia, tolerance

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [341 - 355]
Pages: 15
DOI: 10.2174/1568026053544515
Price: $65

Article Metrics

PDF: 6